Referral to emergency
If any of the following are present or suspected, please refer the patient to the emergency department (via ambulance if necessary) or seek emergent medical advice if in a remote region.
- haematemesis
- haemodynamic instability
- suspected obstruction/pseudo-obstruction
- suspected gastric outlet obstruction
Please contact the on-call registrar to discuss your concerns prior to referral.
For clinical advice, please telephone the relevant metropolitan Local Health Network switchboard and ask to speak to the relevant specialty service.
Central Adelaide Local Health Network
- Royal Adelaide Hospital (08) 7074 0000
- The Queen Elizabeth Hospital (08) 8222 6000
-
Upper GI Cancer Nurse Consultant 0401 123 798
Southern Adelaide Local Health Network
- Barrett’s Oesophagus Surveillance (BOSS) Program (08) 8204 4991
-
Upper GI Cancer Nurse Consultant 0459 837 722
Northern Adelaide Local Health Network
- Lyell McEwin Hospital (08) 8182 9000
-
Upper GI Cancer Nurse Consultant 0435 656 943
Category 1 (appointment clinically indicated within 30 days)
- suspected oesophagogastric malignancy
Appointments usually provided within 7 days
Category 2 (appointment clinically indicated within 90 days)
- nil
Category 3 (appointment clinically indicated within 365 days)
- nil
For more on outpatient referrals, see the general referral information page.
Essential referral information
Completion required before first appointment to ensure patients are ready for care. Please indicate in the referral if the patient is unable to access mandatory tests or investigations as they incur a cost or are unavailable locally.
- identifies as Aboriginal and/or Torres Strait Islander
- relevant social history, including identifying if you feel your patient is from a vulnerable population and/or requires a third party to receive correspondence on their behalf
- interpreter required
- past medical/surgical history
- medications and allergies
- presence of unresolved psychological or psychiatric pathologies
- smoking/alcohol and other drug status
- age
- height/weight
- body mass index
- history of presenting complaint
- concerning features for example, nausea/vomiting, abdominal pain, bloating, unintentional weight loss
- duration and frequency of symptoms
- previous management trialled and efficacy
- pathology:
- complete blood examination (CBE)
- electrolytes urea and creatinine (EUC)
- liver function test (LFT)
- glycated haemoglobin (HbA1c) if diabetic
- iron (FE) studies
- lipase/amylase
- chest-abdomen-pelvis computed tomography (CT)
- reports of prior gastroscopies and pathology results of specimens
- relevant diagnostic/imaging reports including location of company and accession number
Clinical management advice
The use of proton pump inhibitors is advised as part of first-line management for oesophageal and gastric cancer.